Specialist

Q2 saw new lending of £507m

Toby Thompson, manager of the Brooks Macdonald Global Equity Income fund, analyses if equity investors are right to be concerned about the concentration of income from only a limited number of mega-cap companies

Former F&C Thames River managers Kristof Bulkai, Patrick Cadell and Hugo Rogers are to join Liontrust Asset Management to run global portfolios.

AXA IM has hired a sell-side healthcare specialist as the permanent replacement for former Health fund manager Gemma Game, who left the group last year.

Lessons from Silicon Valley's tech companies

Shell's planned £47bn takeover of BG Group could present ethical funds with a new dilemma as it removes one of their largest potential investments.

Aberdeen Asset Management is set to buy the remaining stake in its joint venture with SVG Capital, Aberdeen SVG Private Equity.

Woodford Investment Management, Ruffer, Sarasin and Invesco are among the groups backing a new share placing by Oakley Capital's private equity trust.

Investors are showing increasing willingness to pay for R&D pipelines in biotech, explains AXA Framlington's Linden Thomson.

With discounts on listed private equity trusts almost back to long-term averages, value in the sector can be hard to find. But Ben Williams, investment manager at Saunderson House, argues the improving merger and acquisition market is likely to benefit...